[{"id":"bdf79ea5-8210-46ea-be22-221f8b052253","acronym":"TILS001","url":"https://clinicaltrials.gov/study/NCT05451784","created_at":"2022-07-11T11:54:53.836Z","updated_at":"2024-07-02T16:35:28.136Z","phase":"Phase 1/2","brief_title":"Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS","source_id_and_acronym":"NCT05451784 - TILS001","lead_sponsor":"Fundacio Clinic Barcelona","biomarkers":" HER-2 • PD-1","pipe":" | ","alterations":" HER-2 negative • PD-1 expression • PGR expression","tags":["HER-2 • PD-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative • PD-1 expression • PGR expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NUMARZU-001"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 07/20/2022","start_date":" 07/20/2022","primary_txt":" Primary completion: 11/30/2025","primary_completion_date":" 11/30/2025","study_txt":" Completion: 09/30/2027","study_completion_date":" 09/30/2027","last_update_posted":"2023-11-24"}]